/
INCR
$1.04-$0.00 (-0.16%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$59.4M
57M shares
52-week range
$0.68 – $1.77
33% from low
Exchange
NASDAQ
CS
Borrow rate
10.81%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-5.71
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $8.9M | $65.0M | $219.7M | $388.7M | $355.6M | $238.8M | $270.2M |
| Cost of revenue | $0 | $7.4M | $33.1M | $128.5M | $233.6M | $250.5M | $208.6M | $237.0M |
| Gross profit | $0 | $1.5M | $32.0M | $91.1M | $155.1M | $105.1M | $30.2M | $33.2M |
| Gross margin | — | 16.6% | 49.2% | 41.5% | 39.9% | 29.6% | 12.7% | 12.3% |
| R&D | $0 | $1.7M | $1.6M | $1.2M | $632.0K | $388.0K | $414.0K | $390.0K |
| Operating income | −$10.6M | −$3.4M | −$38.4M | $28.2M | $50.6M | −$41.6M | −$67.2M | $6.7M |
| EBITDA | −$10.1M | −$3.8M | −$34.5M | $31.2M | $70.2M | −$23.9M | −$51.3M | −$7.3M |
| Net income | −$12.8M | −$5.9M | −$37.2M | $4.7M | $44.8M | −$62.0M | −$67.8M | −$35.7M |
| Net margin | — | -66.0% | -57.2% | 2.1% | 11.5% | -17.4% | -28.4% | -13.2% |
| EPS (diluted) | -0.62 | -0.13 | -1.47 | 0.11 | 0.99 | -1.36 | -1.42 | -0.63 |
Annual figures · source: Financial Modeling Prep
Peer comparison
Intercure Ltd. Ordinary Shares
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
www.intercure.co- Employees
- 285
- IPO / List date
- Jan 1, 2019
Held by traders on TradeandTell
No one on the platform currently holds INCR.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in INCR as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded INCR yet.
